No.36 - ALEXANDRE MERIEUX (BIOMERIEUX)
Years at current company: 5
Rate of growth: 43.7% since 2014
Although it is only a year since he officially took over the company founded by his father in 1963, Alexandre Merieux has been presiding over the destiny of this family group for much longer. Joining the company in 2005, he held the position of CEO from 2014. He therefore actively participated in the acquisition of the American competitor BioFire in 2014 ‒ which enabled the group to strengthen its position as a world leader in infectious disease diagnostics.
Notable success: In his first year as chairman, BioMerieux's sales rose by 10%.
The European Commission’s approval of the copyright directive in April threw more gas on the fire. In a few years, the internet has become – among other things – the main market fo...
The long-serving boss of Cobepa, Jean-Marie Laurent Josi talks about the business model of a Belgian investment firm that is trusted by major European families, one which marries t...
Since the last half of 2008, it is no longer possible to conceal the term ‘crisis’. New paradigms have become apparent and structural changes are predicted. Indeed mar...